Interwest Partners

Interwest Partners is one of the longest-running venture capital firms in Silicon Valley, established in 1979. The firm has spent over four decades identifying and supporting IT and healthcare founders building transformative companies in information technology and healthcare.

With approximately $750M targeted for their latest fund, Interwest has maintained a consistent investment approach centered on early-stage opportunities. Their typical investment range of $7-15M over the life of a portfolio company reflects a disciplined approach to deploying capital across a concentrated portfolio.

The firm's investment thesis centers on identifying category-defining companies before they become obvious winners. Interwest has developed deep sector expertise in both IT and healthcare, allowing them to provide meaningful guidance to founders navigating complex market dynamics.

259 companies have received Interwest capital over the firm's history, with notable successes demonstrating the ability to identify winners across multiple market cycles. The firm's longevity provides a significant advantage: LP relationships and founder networks that newer funds cannot replicate.

For founders seeking early-stage capital, Interwest represents a partner with deep industry connections and a patient, research-driven approach to building lasting companies.

Interwest Partners maintains a focused investment thesis centered on early-stage companies in information technology and healthcare. The firm's approach emphasizes deep sector expertise and long-term partnership with founders building category-defining businesses.

In information technology, Interwest targets software, infrastructure, and emerging technology platforms. The firm looks for companies addressing large market opportunities with differentiated technology and clear paths to market leadership.

Healthcare investments span medical devices, therapeutics, diagnostics, and health IT. Interwest's healthcare team combines scientific expertise with commercial acumen to evaluate opportunities across the healthcare continuum.

The firm's investment philosophy centers on conviction-based investing. Rather than spreading capital across many opportunities, Interwest prefers to make meaningful investments in companies where they have high confidence in the team's ability to execute.

Due diligence at Interwest combines rigorous financial analysis with extensive customer and technical reference calls. The firm's long tenure provides access to industry experts and thought leaders who inform investment decisions.

Interwest typically leads or co-leads rounds, providing not just capital but strategic guidance and operational support. The firm's partners have founded and operated companies themselves, bringing operational experience to portfolio relationships.

Interwest has maintained consistent investment activity in recent years, deploying capital across IT and healthcare sectors. The firm's disciplined approach has allowed them to remain active even as many investors pulled back from early-stage deals.

Recent healthcare investments have focused on medical devices and health IT platforms addressing systemic healthcare challenges. The firm sees significant opportunity in companies improving healthcare delivery efficiency and patient outcomes.

IT investments have leaned toward enterprise software and infrastructure, reflecting conviction in B2B software growth despite market volatility. Interwest maintains a research-driven pipeline development approach that identifies opportunities before they become widely known.

The firm's ability to leverage decades of industry relationships provides deal flow advantages. Many Interwest investments originate from founder referrals and industry expert introductions rather than cold inbound traffic.

Follow-on investment is a key part of Interwest's strategy. The firm has demonstrated willingness to significantly increase positions in portfolio companies that hit milestones and demonstrate clear paths to market leadership.

Interwest's portfolio spans multiple successful exits and ongoing growth companies. Cardiac Dimensions represents the firm's healthcare thesis—medical technology addressing structural heart disease with differentiated intellectual property.

mParticle exemplifies the IT portfolio—enterprise customer data infrastructure enabling brands to unify customer analytics across platforms. The company's growth reflects the broader enterprise data platform expansion.

Chingari illustrates Interwest's willingness to invest in emerging consumer platforms with strong engagement metrics and clear monetization paths in the Indian market.

The portfolio's diversity reflects Interwest's conviction that exceptional founders exist across sectors and geographies. The firm has demonstrated ability to identify winners in both enterprise and consumer contexts.

Portfolio companies benefit from Interwest's extensive network of industry executives, advisors, and potential acquisition partners. The firm's long tenure creates relationships across corporate development teams at major technology and healthcare companies.

Interwest evaluates early-stage opportunities based on team quality, market opportunity, and competitive differentiation. The firm's long history provides benchmarks for identifying characteristics that predict success.

Team evaluation focuses on domain expertise and execution capability. Interwest looks for founders who've directly addressed the problem space before and can demonstrate rapid learning ability and operational excellence.

Market size and trajectory matter significantly. Interwest prefers large total addressable markets with clear paths to significant revenue—companies that can become category leaders rather than niche players.

Competitive positioning must be demonstrable, not aspirational. The firm evaluates technical differentiation, intellectual property, and customer adoption metrics that indicate sustainable advantages.

Business model clarity is essential. Interwest wants to understand revenue mechanics and unit economics before investment—companies with complex or unproven business models require more scrutiny.

Warm introductions from trusted sources remain the primary path to Interwest. The firm's partner network and founder referrals provide consistent deal flow—cold outreach rarely generates meetings without compelling credentials.

Industry conference participation and startup ecosystem events provide opportunities to build relationships with Interwest partners. The firm's longevity means they have relationships across multiple entrepreneurial communities.

For healthcare opportunities, connections through medical industry experts and healthcare service providers can facilitate introductions. Interwest's healthcare team values industry relationships that provide deal flow and diligence support.

For IT opportunities, enterprise software and infrastructure conferences provide venues for meeting Interwest partners. The firm's domain expertise means they recognize quality early in category formation.

Follow-on performance matters for ongoing relationship building. Portfolio companies that execute well see continued Interwest engagement in subsequent rounds.

Early-stage companies seeking Interwest capital benefit from demonstrating financial clarity. The firm values founders who understand their unit economics and can explain business mechanics clearly.

Financial modeling for early-stage companies should reflect realistic growth assumptions grounded in customer data. Interwest scrutinizes projections and challenges optimistic scenarios.

Working with experienced finance leadership helps founders prepare investor materials and board reporting that matches institutional expectations.

Understanding burn rate, runway, and path to profitability or next funding round is essential for early-stage discussions. Interwest evaluates financial management capability alongside business potential.

Preparing for early-stage fundraising with Interwest requires clear business mechanics and realistic financial projections. Our team helps founders build investor-ready financial infrastructure and pitch materials that demonstrate the clarity Interwest values.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you're looking for seed-stage investors or growth equity firms, you'll find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take the time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.